Clinical Trial: Evaluation of the Efficacy and Safety of 102D-6 in the Treatment of Acute Uncomplicated Influenza

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07893847) titled 'Evaluation of the Efficacy and Safety of 102D-6 in the Treatment of Acute Uncomplicated Influenza' on Oct. 18.

Brief Summary: The goal of this Phase II/III study is to investigate the safty and efficacy of 102D-6 in adolescents and adults with influenza.

The main aim to answer:

1. Phase II study is to evaluate the efficacy of 102D-6 in the treatment of adult influenza subjects and determine the optimal therapeutic dose by analyzing the time of virus titer turning to negative. The results will be used to design the Phase III study.

2. Phase III study is to evaluate the efficacy of 102D-6 by analyzing the duration of remission of a...